Delivery Order SPE2DB22D3004-SPE2DB25FPH46

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imiquimod 5% Cream Packets 24s. The contract, valued at $1,726.61, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, with an ID of SPE2DX15D7062|SPE2DX25FJCZT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,020.00 firm fixed-price delivery order is for the supply of IMIQUIMOD 5% CREAM 24S, a medical product, with a completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,307.81 firm fixed-price delivery order is for the supply of Imiquimod 5% Cream Packets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which supports the provision of a broad range of pharmaceutical products and medical supplies to military healthcare...
This federal contract award, SPE2DB22D2007|SPE2DB25FH8PA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.35 Firm Fixed Price delivery order is for the supply of IMIQUIMOD 5% CREAM PACKET 24S medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $2,836.23, is for the delivery of Imiquimod 3.75% cream in 28-count packages. The contract has a firm fixed price and a completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
The Defense Logistics Agency Troop Support Medical awarded a $82,080 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for IMIQUIMOD CREAM. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the location of performance in Conshohocken, Pennsylvania within the period of performance between August 10-11, 2023. The parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation, will support delivery under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,013.34 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a topical medication. The contract has an ultimate completion date of August 31, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,274.72 contract is for the delivery of SF 5000 PLUS CREAM 51GM, with a completion date of November 2, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,685.48 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 30 gm, a pharmaceutical product. The contract has a completion date of February 7, 2022 and was awarded on February 4, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,377.22, is a Firm Fixed Price Delivery Order for the supply of a prescription ointment product. The contract has a period of performance through November 2024 and is not designated as a set-aside requirement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPH46
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,004.15, is a delivery order for the supply of IMIQUIMOD 5% CREAM PACKET 24S. It is a firm fixed-price contract with an ultimate completion date of January 30, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition.

Generated 4/30/25, 10:11 AM